One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization

Journal of Medicinal Chemistry

Volumn 45, Issue 12, 2002, Pages 2670-2673

  Flynn, Bernard L ^a   Hamel, Ernest ^b   Jung, M Katherine ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; INDOLE DERIVATIVE; TUBULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; MICROTUBULE ASSEMBLY; REACTION ANALYSIS;

ANTINEOPLASTIC AGENTS; BENZOFURANS; BIOPOLYMERS; CELL DIVISION; COLCHICINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDOLES; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0037030605     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020077t     Document Type: Article

References (32)

1. Colchicine: 1998 Update
2. The benzimidazole anthelmintic agents - A review
3. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
4. Vinorelbine - A clinical review
5. Paclitaxel (taxol)
6. Docetaxel
7. Antivascular approaches to solid tumour therapy: Evaluation of tubulin binding agents
8. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
9. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
10. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4
11. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
12. Tumor vasculature as a target for cancer therapy
13. Combretastatins: Novel vascular targeting drugs for improving anticancer therapy. Combretastatins and conventional therapy
14. Anti-vascular approaches to solid tumor therapy: Evaluation of combretastatin A4 phosphate
15. Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumor vascular targeting activity in vivo
16. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
17. Antimitotic natural products combretastatin A-4 and combretastatin A-2: Studies on the mechanism of their inhibition of the binding of colchicine to tubulin
18. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)
19. A new anti-tubulin agent containing the benzo[b]thiophene ring system
20. Characterization and structural analyses of trimethoxy and triethoxybenzo[b]thiophene
21. Synthesis of a benzo[b]thiophene-based vascular targeting prodrug and related antitubulin ligands
22. A novel palladium mediated coupling approach to 2,3-disubstituted benzo[b]thiophenes and its application to the synthesis of tubulin binding agents
23. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
24. A multi-component coupling approach to benzo[b]furans and indoles
25. Selective cleavage of isopropyl aryl ethers by aluminum trichloride
26. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells
27. A versatile approach to 2,3-disubstituted indoles through the palladium-catalyzed cyclization of o-alkynyltrifluoroacetanilides with vinyl triflates and aryl halides
28. 2-Substituted-3 acylindoles through the palladium-catalyzed carbonylative cyclization of 2-alkynyltrifluoracetanilides with aryl halides and vinyl triflates
29. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization